text: These data are consistent with previous reports that exposure of the developing brain to NMDA antagonists such as ketamine or PCP results in widespread and dose-dependent apoptotic neurodegeneration (Ikonomidou et al., 1999, 2001; JevtovicTodorovic et al., 2003; Olney et al., 2002).